Perino J, Demourgues M, Ramaroson H, Bezin J, Micallef J, Miremont-Salamé G, Frauger E, Gilleron V, Ong N, Daveluy A. Increase in hospitalisation-associated methadone intoxication in France following first COVID-19 lockdown. Public Health. 2023 Aug 10;223:1-6. doi: 10.1016/j.puhe.2023.07.004. Epub ahead of print. PMID: 37572562.
E. Frauger, N. Fouilhé, C. Lacroix et al., Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020, Therapies
Guerlais M, Aquizerate A, Lionnet A, Daveluy A, Duval M, Gérardin M, Istvan M, Laforgue EJ, Victorri-Vigneau C. for French Addictovigilance Network – Nitrous oxide: a unique official French addictovigilance national survey. Front Public Health. 2023 May 3;11:1167746. doi: 10.3389/fpubh.2023.1167746. PMID: 37206871; PMCID: PMC10189051.
Nitrous oxide: a unique official French addictovigilance national survey. Lire la suite »
Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. Int J Drug Policy. 2023 Jun 8;118:104082. doi: 10.1016/j.drugpo.2023.104082. Epub ahead of print. PMID: 37336071; PMCID: PMC10247883.
Mezaache S, Turlure F, Fredon N, Le Brun Gadelius M, Micallef J, Frauger E. Prévention des surdoses opioïdes et diffusion de naloxone (programme POP) : résultats d’un état des lieux réalisé auprès des structures d’addictologie [Opioid overdose prevention and naloxone diffusion (POP program): Results of an overview conducted among addiction specialized centres]. Therapie. 2023 Mar 15:S0040-5957(23)00057-4. French.
Aquizerate, A., Laforgue, EJ., Istvan, M. et al. Evolution of the Addictovigilance Signal of Zopiclone: A 2014–2020 National Follow-up Study. Int J Ment Health Addiction (2023).
Soeiro T, Pradel V, Lapeyre-Mestre M, Micallef J. Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nationwide, repeated cross-sectional study. Addiction. 2023 May 19. doi: 10.1111/add.16261. Epub ahead of print. PMID: 37203878
L. Diaz, C. Eiden, E. Jouanjus et al., Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020, Therapies
Aquizerate A, Laforgue EJ, Istvan M, Rousselet M, Gerardin M, Jouanjus E, Libert F; French Addictovigilance Network; Guerlais M, Victorri-Vigneau C. French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. Eur J Public Health. 2023 Feb 7:ckad003. doi: 10.1093/eurpub/ckad003. Epub ahead of print.
Peyriere H, Jacquet JM, Peries M, Tribout V, Broche B, Mauboussin JM, Makinson A, Perrollaz C, Ferreyra M, Rouanet I, Montoya-Ferrer A, El-Majjaoui S, Corriol-Bonifas F, Fraisse T, Grau F, Laureillard D, Nagot N, Reynes J, Donnadieu-Rigole H. Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. Fundam Clin Pharmacol. 2022 Nov 20.